$164B
$211 Billion
33.13% of portfolio
9,603,558
Q3 2024
Reduced 8.39%
$1.29B
$107 Billion
16.73% of portfolio
6,547,483
Q3 2024
Reduced 20.12%
$366M
$99.6 Billion
15.61% of portfolio
10,181,070
Q1 2024
Added 44.61%
$2.67B
$52.9 Billion
8.3% of portfolio
17,186,079
Q3 2024
Reduced 11.08%
$1.81B
$38.9 Billion
6.1% of portfolio
754,415
Q3 2024
Reduced 21.2%
$1.5B
$18.8 Billion
2.95% of portfolio
2,047,323
Q3 2024
Added 91.87%
$1.24B
$15.9 Billion
2.49% of portfolio
2,216,410
Q3 2024
Reduced 22.24%
$130M
$13.9 Billion
2.18% of portfolio
5,395,100
Q3 2024
Reduced 15.86%
$715M
$12.7 Billion
1.99% of portfolio
504,398
Q3 2024
Reduced 0.55%
$0
$11.5 Billion
1.8% of portfolio
9,889,569
Q3 2024
Added 2,378.28%
$1.34B
$10.7 Billion
1.67% of portfolio
170,226
Q3 2024
Reduced 75.31%
-
$5.37 Billion
0.84% of portfolio
-
Q3 2024
New
Praxis Precision Medicines I
-
$3.87 Billion
0.61% of portfolio
-
Q3 2024
New
$641M
$3.81 Billion
0.6% of portfolio
438,200
Q3 2024
New
$1.08B
$3.39 Billion
0.53% of portfolio
95,810
Q3 2024
New
$2.94B
$3.23 Billion
0.51% of portfolio
45,310
Q3 2024
Reduced 87.36%
$27.4B
$2.88 Billion
0.45% of portfolio
251,125
Q1 2023
New
$219B
$2.7 Billion
0.42% of portfolio
40,925
Q3 2024
Reduced 98.15%
Adverum Biotechnologies Inc
-
$2.16 Billion
0.34% of portfolio
-
Q3 2024
New
$528M
$1.85 Billion
0.29% of portfolio
442,298
Q3 2024
Reduced 31.14%
Mineralys Therapeutics Inc
-
$1.66 Billion
0.26% of portfolio
-
Q3 2024
Added 292.39%
$811M
$1.66 Billion
0.26% of portfolio
336,468
Q3 2024
Added 412.91%
$103M
$1.44 Billion
0.23% of portfolio
734,904
Q3 2024
Added 1,779.21%
-
$1.32 Billion
0.21% of portfolio
-
Q3 2024
New
$1.29B
$1.24 Billion
0.19% of portfolio
99,938
Q3 2024
New
$38.4M
$1.07 Billion
0.17% of portfolio
1,602,792
Q3 2024
Added 805.37%
$161M
$1 Billion
0.16% of portfolio
133,271
Q3 2024
New
$51.3M
$1.03 Billion
0.16% of portfolio
510,724
Q3 2024
Added 3,078.12%
$116M
$986 Million
0.15% of portfolio
188,537
Q3 2024
Added 384.66%
$1.93B
$373 Million
0.06% of portfolio
59,289
Q3 2024
Added 236.47%
$1.18B
$351 Million
0.06% of portfolio
37,375
Q3 2024
Added 154.25%
-
$325 Million
0.05% of portfolio
-
Q3 2024
New
$79.2M
$230 Million
0.04% of portfolio
52,985
Q3 2024
Added 35.86%
$541M
$279 Million
0.04% of portfolio
24,462
Q3 2024
Added 112.27%
-
$275 Million
0.04% of portfolio
-
Q3 2024
New
Creative Media & Cmnty Tr
-
$239 Million
0.04% of portfolio
-
Q3 2024
Added 11.69%
$187M
$260 Million
0.04% of portfolio
17,458
Q3 2024
Added 49.82%
$293M
$237 Million
0.04% of portfolio
254,963
Q3 2024
Added 53.4%
$58.3M
$218 Million
0.03% of portfolio
43,723
Q3 2024
Added 102.67%
$346M
$221 Million
0.03% of portfolio
45,600
Q3 2024
New
$1.87B
$205 Million
0.03% of portfolio
7,686
Q3 2024
New
$164M
$212 Million
0.03% of portfolio
32,309
Q3 2024
Added 126.06%
$188M
$120 Million
0.02% of portfolio
24,000
Q3 2024
New
Achieve Life Sciences Inc
-
$157 Million
0.02% of portfolio
-
Q3 2024
New
Syros Pharmaceuticals Inc
-
$106 Million
0.02% of portfolio
-
Q3 2024
New
$182M
$118 Million
0.02% of portfolio
24,289
Q3 2024
New
$36.4M
$50 Million
0.01% of portfolio
22,026
Q3 2024
New
Cellectar Biosciences Inc
-
$53.6 Million
0.01% of portfolio
-
Q3 2024
New
$39.3M
$49.2 Million
0.01% of portfolio
10,500
Q3 2024
New
$135M
$51.7 Million
0.01% of portfolio
24,291
Q3 2024
Reduced 30.72%